Comparative inhibition of inducible and constitutive CYPs in rat hepatic microsomes by parathion

Reference

• BENSOUSSAN, C., DELAFORGE, M. and MANSUY, D., 1995, Particular ability of cytochromes CYP 3A to form inhibitory CYP-iron-metabolite complexes upon metabolic oxidation of aminodrugs. Biochemical Pharmacology, 49, 591–602.
   PubMed Web of Science ®Google Scholar
• BOCKER, R. H. and GUENGERICH, F. P., 1986, Oxidation of 4-aryl- and 4-alkyl-substituted 2,6-dimethy1-3,5-bis(alkoxycarbony1)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450. Journal of Medicinal Chemistry, 29, 1596–1603.
   Google Scholar
• BURATTI, F. M., VOLPE, M. T., MENEGUZ, A., VITTOZZI, L. and TESTAI, E., 2003, CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. Toxicology and Applied Pharmacology, 186, 143–154.
   PubMed Web of Science ®Google Scholar
• BUTLER, A. M. and MURRAY, M., 1993, Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion. Molecular Pharmacology, 43, 902–908.
   PubMed Web of Science ®Google Scholar
• BUTLER, A. M. and MURRAY, M., 1997, Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. Journal of Pharmacology and Experimental Therapeutics, 280, 966–973.
   PubMed Web of Science ®Google Scholar
• DEMATTEIS, F., 1974, Covalent binding of sulfur to microsomes and loss of cytochrome P-450 during the oxidative metabolism of several chemicals. Molecular Pharmacology, 10, 849–854.
   Web of Science ®Google Scholar
• FRANKLIN, M. R., 1977, Inhibition of mixed-function oxidases by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmacology and Therapeutics A, 2, 227–245.
   Web of Science ®Google Scholar
• FRANKLIN, M. R., 1995, Enhanced rates of cytochrome P450 metabolic-intermediate complex formation from nonmacrolide amines in rifampicin-treated rabbit liver microsomes. Drug Metabolism and Disposition, 23, 1379–1382.
   PubMed Web of Science ®Google Scholar
• HOEN, P. A. C.'t., COMMANDEUR, J. N. M., VERMEULEN, N. P. E., VAN BERKEL, T. J. C. and BIJSTERBOSCH, M. K., 2000, Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes. Analysis with a novel reverse transcriptase-polymerase chain reaction assay. Biochemical Pharmacology, 60, 1509–1518.
   Google Scholar
• HONKAKOSKI, P., ZELKO, I., SUEYOSHI, T. and NEGISHI, M., 1998, The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B6 gene. Molecular and Cellular Biology, 18, 5652–5658.
   PubMed Web of Science ®Google Scholar
• HURH, E., LEE, E., LEE, A., KIM, Y., KIM, S., Km, S. and LEE, M., 2000, Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous parathion in rats. Biopharmaceutics and Drug Disposition, 21, 193–204.
   PubMed Web of Science ®Google Scholar
• JEFCOATE, C. R., 1978, Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical difference spectroscopy. Methods in Enzymology, 52, 258–279.
   PubMedGoogle Scholar
• KLIEWER, S. A., MOORE, J. T., WADE, L., STAUDINGER, J. L., WATSON, M. A., JONES, S. A., McKEE, D. D., OLIVER, B. B., WILLSON, T. M., ZETTERSTROM, R. H., PERLMANN, T. and LEHMANN, J. M., 1998, An orphan nuclear receptor activated by pregnanes defines a novel steroid signalling pathway. Cell, 92, 73–82.
   PubMed Web of Science ®Google Scholar
• LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• LIN, H. L., ZHANG, H., WASKELL, L. and HOLLENBERG, P. F., 2003, Threonine-205 in the F helix of P450 2B1 contributes to androgen 163-hydroxylation activity and mechanism-based inactivation. Journal of Pharmacology and Experimental Therapeutics, 306, 744–751.
   PubMed Web of Science ®Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MAHNKE, A., STROTKAMP, D., Roos, P. H., HANSTEIN, W. G., CHABOT, G. G. and NEF, P., 1997, Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Archives of Biochemistry and Biophysics, 337, 62–68.
   PubMed Web of Science ®Google Scholar
• MARTINI, R., BUTLER, A. M., JIANG, X.-M. and MURRAY, M., 1995, Pretranslational down regulation of cytochrome P450 2C11 in vitamin A-deficient male rat liver: prevention by dietary inclusion of retinoic acid. Journal of Pharmacology and Experimental Therapeutics, 273, 427–434.
   Google Scholar
• McNEIL, C. M. and MURRAY, M., 1996, Inhibition of microsomal cytochromes P450 in rat liver by the tricyclic antidepressant drug desipramine and its primary oxidized metabolites. Biochemical Pharmacology, 51, 15–20.
   PubMed Web of Science ®Google Scholar
• MUAKKASAH, S. F., BIDLACK, W. R. and YANG, W. C. T., 1981, Mechanism of the inhibitory action of isoniazid on microsomal drug metabolism. Biochemical Pharmacology, 30, 1651–1658.
   PubMed Web of Science ®Google Scholar
• MURRAY, M., 1988, Complexation of cytochrome P450 isozymes in hepatic microsomes from SKF-525-A-induced rats. Archives of Biochemistry and Biophysics, 262, 381–388.
   PubMed Web of Science ®Google Scholar
• MURRAY, M., 1992, Metabolite intermediate complexation of microsomal cytochrome CYP 2C11 in male rat liver by nortriptyline. Molecular Pharmacology, 42, 931–938.
   PubMed Web of Science ®Google Scholar
• MURRAY, M. and BUTLER, A. M., 1995, Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion. Journal of Pharmacology and Experimental Therapeutics, 272, 639–644.
   PubMed Web of Science ®Google Scholar
• MURRAY, M. and MURRAY, K., 2003, Mechanism-based inhibition of CYP activities in rat liver by fiuoxetine and structurally similar alkylamines. Xenobiotica, 33, 973–987.
   PubMed Web of Science ®Google Scholar
• MURRAY, M., SEFTON, R. M., MARTINI, R. and BUTLER, A. M., 1999, Comparative induction of CYP3A and CYP2B in rat liver by 3-benzoylpyridine and meyrapone. Chemico-Biological Interactions, 113, 161–173.
   Google Scholar
• NORMAN, B. J., POORE, R. E. and NEAL, R. A., 1974, Studies of the binding of sulfur released in the mixed-function oxidase-catalyzed metabolism of diethyl p-nitrophenyl phosphorothioate (parathion) to diethyl p-nitrophenyl phosphate (paraoxon). Biochemical Pharmacology, 23, 1733–1744.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R., 1964, The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• ORTIZ DE MONTELLANO, P. R. and Mico, B. A., 1980, Destruction of cytochrome P-450 by ethylene and other olefins. Molecular Pharmacology, 18, 128–135.
   PubMed Web of Science ®Google Scholar
• REIDY, G. F., MEHTA, I. and MURRAY, M., 1989, Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics. Molecular Pharmacology, 35, 736–743.
   PubMed Web of Science ®Google Scholar
• REIN, H., RISTAU, 0., MISSELWITZ, R., BUDER, E. and RUCKPAUL, K., 1979, The importance of the spin equilibrium in cytochrome P-450 for the reduction rate of the heme iron. Acta Biologica et Medica Germanica, 38, 187–199.
   Google Scholar
• ROBERTS, E. S., HOPKINS, N. E., ALWORTH, W. L. and HOLLENBERG, P. F., 1993, Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide. Chemical Research in Toxicology, 6, 38–45.
   PubMed Web of Science ®Google Scholar
• SEGEL, I., 1975, in Enzyme Kinetics: Behaviour and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems (New York: Wiley), pp. 100–226.
   Google Scholar
• SULTATOS, L. G., 1986, The effects of phenobarbital pretreatment on the metabolism and acute toxicity of the pesticide parathion in the mouse. Toxicology and Applied Pharmacology, 86, 105–111.
   PubMed Web of Science ®Google Scholar
• SUTTON, D., BUTLER, A. M., NADIN, L. and MURRAY, M., 1997, Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. Journal of Pharmacology and Experimental Therapeutics, 282, 294–300.
   PubMed Web of Science ®Google Scholar
• TRIEU, L. and MURRAY, M., 2000, Metabolite—intermediate complexation and inhibition of microsomal CYP3A in rat liver by diltiazem. Xenobiotica, 30, 131–140.
   PubMed Web of Science ®Google Scholar
• VON WACHENFELDT, C. and JOHNSON, E. F., 1995, Structures of eukaryotic cytochrome P450 enzymes. In P. P. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd edn (New York: Plenum), pp. 183–223.
   Google Scholar
• WAXMAN, D. J., Ko, A. and WALSH, C., 1983, Regioselectivity and stereoselectivity of androgen hydroxylations catalysed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. Journal of Biological Chemistry, 258, 11937–11947.
   PubMed Web of Science ®Google Scholar